Invitrogen™ Human NOD1 Synthetic Peptide
NOD1 Synthetic Peptide, PEP-1129, from Invitrogen.
- Gene ID (Enter)
- 10392
- Species
- Human
- Purification method
- Purified
- Accession number
- Q9Y239
- Common name
- Human NOD1
- Brand
- Invitrogen
NOD1 Synthetic Peptide, PEP-1129, from Invitrogen.
NOD1 Synthetic Peptide, PEP-1129, from Invitrogen.
NOD1 is a member of the NOD (nucleotide-binding oligomerization domain) family, a group of proteins that are involved in innate immune defense. NOD1 contains an N-terminal caspase recruitment domain (CARD), a centrally located nucleotide-binding domain (NBD), and ten tandem leucine-rich repeats (LRRs) in its C-terminus. The CARD is involved in apoptotic signaling, and NOD1 activates caspase-9 and NF-kappa-B. LRRs participate in protein-protein interactions, and mutations in the NBD may affect the process of oligomerization and subsequent function of the LRR domain. This protein is an intracellular pattern-recognition receptor (PRR) that initiates inflammation in response to a subset of bacteria through the detection of bacterial diaminopimelic acid.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15265129 |
| Specifications | |
| Gene ID (Enter) | 10392 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q9Y239 |
| Common name | Human NOD1 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | NOD1 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-1129 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |